These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension. Longhurst PA; Rice PJ; Taylor DA; Fleming WW Hypertension; 1988 Aug; 12(2):133-42. PubMed ID: 3410523 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related]
50. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension. Wang H; McNeill JR Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814 [TBL] [Abstract][Full Text] [Related]
51. Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor. Pendleton RG; Kaiser C; Gessner G J Pharmacol Exp Ther; 1976 Jun; 197(3):623-32. PubMed ID: 6786 [TBL] [Abstract][Full Text] [Related]
52. Withdrawal-induced antihypertensive effect of vasopressin in Doca-salt hypertension. Chiu EK; McNeill JR Am J Hypertens; 1989 Jun; 2(6 Pt 1):458-61. PubMed ID: 2757802 [TBL] [Abstract][Full Text] [Related]
53. Chronic Blockade of Brain Endothelin Receptor Type-A (ET Cassinotti LR; Guil MJ; Schöller MI; Navarro MP; Bianciotti LG; Vatta MS Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495426 [TBL] [Abstract][Full Text] [Related]
54. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177 [TBL] [Abstract][Full Text] [Related]
55. Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced. Buñag RD Eur J Pharmacol; 1977 Jun; 43(4):323-31. PubMed ID: 880980 [TBL] [Abstract][Full Text] [Related]
56. Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats. Yu M; Gopalakrishnan V; McNeill JR Am J Hypertens; 1999 Aug; 12(8 Pt 1):845-8. PubMed ID: 10480481 [TBL] [Abstract][Full Text] [Related]
57. Effect of adrenaline synthesis inhibition on brain noradrenaline neurons in locus coeruleus. Engberg G; Elam M; Svensson TH Brain Res; 1981 Oct; 223(1):49-58. PubMed ID: 7284809 [TBL] [Abstract][Full Text] [Related]
58. Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion. Spinedi E; Johnston CA; Chisari A; Negro-Vilar A Endocrinology; 1988 May; 122(5):1977-83. PubMed ID: 2834181 [TBL] [Abstract][Full Text] [Related]
59. Examination of the role of the acidic hydrogen in imparting selectivity of 7-(aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) toward inhibition of phenylethanolamine N-methyltransferase vs the alpha 2-adrenoceptor. Grunewald GL; Dahanukar VH; Caldwell TM; Criscione KR J Med Chem; 1997 Dec; 40(25):3997-4005. PubMed ID: 9406590 [TBL] [Abstract][Full Text] [Related]
60. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects. Tanaka M; Masumura H; Tanaka S; Akashi A J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]